Should we modify the current FIGO staging system for stage IIIC ovarian cancer?

Should we modify the current FIGO staging system for stage IIIC ovarian cancer?

History of the FIGO cancer staging system.

The main objectives of any good staging system - essential to an evidence-based approach to cancer - are: to aid the clinician in planning treatment; to provide indication of prognosis; to assist the physician in evaluating the results of treatment; to facilitate the exchange of information between treatment centers, thus disseminating knowledge; and to contribute to continuing investigations i...

2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.

Cancer staging is a core principle in understanding the severity of patients' clinical condition, predicting the outcome, and planning adequate treatment. Staging is necessary for explaining epidemiologic changes, defining the disease at presentation, and evaluating the overall impact of new therapies. In essence, it assigns patients to prognostic groups that require specific treatments. The st...

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer

Although complete debulking surgery for epithelial ovarian cancer (EOC) is more often achieved with interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT), randomized evidence shows no long-term survival benefit compared to complete primary debulking surgery (PDS). We performed an observational cohort study of patients treated with debulking surgery for advanced EOC to evalu...

Interval debulking surgery in patients with Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV ovarian cancer.

BACKGROUND The feasibility of neoadjuvant chemotherapy (NAC) and the outcome in patients with Federation of Gynecology and Obstetrics (FIGO) IIIC and IV ovarian cancer were assessed. PATIENTS AND METHODS 67 patients undergoing interval debulking surgery (IDS) and ≥ 4 courses of platinum-based NAC were analyzed for survival, perioperative morbidity and mortality. RESULTS The median follow-up...